pharma

YOU MIGHT BE INTERESTED IN

The Global OTC Pharmaceutical Market 2010-2025
In 2009, the global over-the-counter (OTC) pharmaceutical market generated revenues of more than $60bn. Our analyses show that total OTC revenues will exceed $70bn by 2015. From 2010 onwards, Rx-to-OTC switching and the continuing importance of emerging healthcare markets will drive sales in this sector. Our forecasts reveal that the OTC pharma market will grow significantly from 2010 onwards. This report explains where future OTC switching and other developments will occur, providing you with the information that you need to understand the current OTC market and its future prospects.
...more details
World Smoking-Cessation Drug Market 2010-2025
Smoking is a leading cause of preventable death worldwide. In 2009, total sales of smoking-cessation products surpassed $1.6bn (Rx products). The effects of smoking constitute a major burden on public healthcare systems, as well as lowering quality of life for many people. Currently-marketed smoking-cessation products arguably lack the desired levels of efficacy in practice, with the reputation of some suffering through noted side-effects. As a result, there are significant commercial opportunities for more-efficacious and better-tolerated smoking-cessation agents, especially in prescription form.
...more details
The Global Analgesics Market 2009-2024
There remain many unmet therapeutic needs in the treatment of pain, as well as high demand for analgesic treatments worldwide. For several types of pain, including conditions such as diabetic neuropathy and sciatica, there are currently few treatments. Furthermore, the pain sector is associated with side effects. Novel compounds that demonstrate improved safety profiles - combined with high efficacies - have the potential to gain significant market shares from 2009 onwards.
...more details
World Respiratory Disorders Market 2009-2024
Respiratory disorder therapies form an important and competitive part of the pharmaceutical market worldwide. There are wide ranges of drugs and therapeutic needs, both acute and chronic. Revenues are high currently, with good potential for sales increases. As the patient population grows and respiratory diseases become more prevalent, the market has the potential for continued growth in many countries and therapeutic areas. Our new pharma report will give you the analytical information that you need to understand current trends and likely future events in this market area.
...more details
The World Antibacterial Treatments Market 2010-2024
Our latest report examines the prospects for antibacterial treatments worldwide from 2009 to 2024, including detailed sales forecasts for leading products in that sector. The global anti-infectives market generated revenues of $79bn for the 12 months to the second-quarter of 2009, of which the antibacterial market accounted for $37bn. How will this market perform from 2010 onwards? Our original forecasts and qualitative analyses will show you how the antibacterial sector will fare, pointing out the most-exciting and fast-growing areas.
...more details
The US Pharmaceutical Market 2009-2024
The United States has by far the world's largest pharmaceutical market. In the twelve months to Q2 2009, the US accounted for 41% of world pharmaceutical sales. Its vast economy, high standard of living, minimal pricing controls and strong intellectual property rights help make it the world's most dominant pharma market. The US also has one of the most stringent regulatory environments in the world. This brand new report - US Pharmaceutical Market 2009-2024 - will provide you with extensive information about the US pharma market and industry to benefit your work.
...more details
The World Dermatological Market Outlook 2010-2024
The dermatological drug market continues to be important and competitive globally. New treatments for skin disorders and increasing disease prevalence will lead to further expansion of that market area, we predict. There are potential gains in all the main aspects of pharma development: novel drugs, drug delivery innovation, generics and biotechnology. Our brand new report - The World Dermatological Market Outlook 2010-2024 - explains why that market will expand, revealing where the most-exciting developments will lie during our forecast period. And how you can benefit from this expansion.
...more details

REPORT

...see all

The Global OTC Pharmaceutical Market 2009-2024

Download report Download sample

Publication date: 21/05/2009
Number of Pages: 146

Report Details
Table of Contents
Companies Listed

Report Details

OTC pharma is influenced by changes in consumer spending - but significant commercial opportunities for OTC switching will drive market expansion worldwide – our new report explains

General economic trends worldwide will affect the over-the-counter (OTC) pharma market from 2009 onwards, with both market restraints and opportunities present. In this new report - The Global OTC Pharmaceutical Market 2009-2024 – visiongain notes that Rx-to-OTC switching and the continuing importance of emerging pharma markets will drive OTC sales growth from 2009 onwards. Our forecasts reveal that the OTC pharma market will grow significantly next decade. This report explains where future OTC switching will occur, providing you with the information that you need to understand the current OTC market and its future prospects. The potential of this market remains significant, despite general economic uncertainty, visiongain asserts.

The Global OTC Pharmaceutical Market 2009-2024 examines all the major categories of OTC pharmaceuticals, including:
• Analgesics – for internal and external uses
• Cough, cold and allergy preparations
• Dermatology - including antifungal agents and hair-loss treatments
• Gastrointestinal drugs - including those for acid-related disorders, laxatives and anti-diarrhoea preparations
• Anti-obesity treatments
• Smoking cessation aids
• Others – including contraceptives, statins and erectile dysfunction areas.

Demographic trends, lifestyles changes and clinical advances are transforming medicine and creating opportunities for therapeutic areas and drug types in OTC pharma. Consumers are increasingly willing to self-medicate, for convenience and cost savings in particular. New regulations are changing OTC retail channels and sales processes, including the range of products on offer. Importantly, governments and healthcare providers are promoting self-medication, viewing the process as a tool to help contain healthcare expenditure. Therefore the OTC pharma market holds high potential for continued growth in both mature and emerging geographical markets.

Taking advantage of such opportunities will take considerable skill in a crowded and competitive marketplace. Competing with private labels, gaining regulatory approval for further OTC switches and harnessing Web 2.0 in advertising are all challenges that are assessed in this report, along with other aspects of the market.

Comprehensive analysis of the OTC market area

The Global OTC Pharmaceutical Market 2009-2024 examines that sector critically, through a comprehensive review of information sources, both primary and secondary. This report provides detailed sales forecasts, discussions of pipeline developments and analysis of commercial drivers and restraints, including a SWOT analysis. There are over 100 tables and figures included. The result is a comprehensive market- and industry-centred report, with detailed analyses and informed opinion to aid your work.

Why you should buy The Global OTC Pharmaceutical Market 2009-2024

Benefits from purchasing this report include:
• Your receiving a comprehensive appraisal of the OTC pharmaceutical market in 2008, including sales revenues and market shares for OTC categories, the top 10 companies and the leading OTC brands
• Your receiving sales forecasts and discussions covering the period 2009 to 2024, including the global OTC market, leading OTC brand forecasts, top OTC manufacturer forecasts and therapeutic category forecasts
• Your viewing sales forecasts for leading national OTC markets worldwide
• Your receiving coverage of OTC switching from 2009 onwards, with important developments that you cannot ignore
• Your viewing strengths, weaknesses, opportunities and threats facing the industry, with an emphasis on commercial drivers and restraints.

You can order this report today

The Global OTC Pharmaceutical Market 2009-2024 will provide you with a greater understanding of the expanding OTC market worldwide. What effect will the current downturn in consumer spending have on the OTC market? What are the OTC product market shares in each of the top-10 OTC companies? Which will be the most-important Rx-to-OTC switches in future? If you want to understand this important market, you can stay ahead by ordering this report today.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1 Executive Summary

2 Introduction to OTC Pharmaceuticals
2.1 OTC Pharmaceuticals
2.2 Key Features of OTC Pharmaceuticals
2.3 OTC Switching
2.4 Manufacture and Distribution of OTC Pharmaceuticals
2.5 Regulation of OTC Pharmaceuticals
2.5.1 United States
2.5.2 Japan
2.5.3 European Union
2.5.4 Other Countries
2.6 Major OTC Pharmaceutical Therapeutic Categories
2.7 Analgesics
2.7.1 Internal Analgesics
2.7.2 External Analgesics
2.8 Cough, Cold and Allergy Products
2.8.1 Cough and Cold Remedies
2.8.2 Anti-Allergy OTC Products
2.9 Dermatological Products
2.9.1 Minor Cuts and Wounds
2.9.2 Acne
2.9.3 Rashes, Itchy Skin, Dermatitis and Eczema
2.9.4 Cold Sores
2.9.5 Warts
2.9.6 Fungal Skin Infections
2.9.7 Haemorrhoids
2.9.8 Other Dermatological Products
2.10 Gastrointestinal Products
2.10.1 Indigestion and Heartburn
2.10.2 Anti-Diarrhoea OTC Pharmaceuticals
2.10.3 Laxatives
2.10.4 Anti-Emetic OTC Pharmaceuticals
2.10.5 Anti-Obesity OTC Pharmaceuticals
2.11 Smoking Cessation Aids
2.12 Other OTC Pharmaceuticals
2.13 Vitamins, Minerals and Supplements

3 The Global OTC Pharmaceutical Market
3.1 Global OTC Pharmaceutical Market
3.1.1 The Global OTC Market in 2008
3.1.2 Economic Downturn and OTC Switching: Global OTC Pharmaceutical Market Forecast, 2009-2024
3.1.3 World OTC Market to Increase 75% from 2008 Value by 2024
3.2 OTC Pharmaceutical Categories
3.2.1 OTC Category Revenues and Market Share, 2008
3.2.2 OTC Category Sales Forecasts, 2009-2024
3.3 Leading OTC Pharmaceutical Brands
3.4 Leading OTC Pharmaceutical Manufacturers
3.5 Johnson & Johnson
3.5.1 Johnson & Johnson’s OTC Pharmaceuticals and Nutritionals Franchise
3.5.2 The Global OTC Leader: Johnson & Johnson’s 2008 OTC Sales Revenues and Market Shares
3.5.3 Johnson & Johnson OTC Pharmaceutical Forecast, 2009-2014
3.5.4 Tylenol: The Only Billion Dollar OTC Brand
3.5.5 Tylenol Sales Forecast, 2009-2024
3.5.6 Johnson & Johnson’s Nicorette Nicotine Replacement Therapy
3.5.7 Nicorette Sales Forecast, 2009-2024
3.5.8 Zyrtec OTC/Reactine: Johnson’s & Johnson’s Fastest-Growing Brand of 2008
3.5.9 Other Leading Johnson & Johnson OTC Pharmaceuticals
3.6 GlaxoSmithKline
3.6.1 GSK Consumer Healthcare
3.6.2 GSK is Second-Largest Global OTC Pharmaceutical Company: 2008 OTC Sales and Market Shares
3.6.3 GSK OTC Pharmaceutical Forecast, 2009-2014
3.6.4 Panadol: GSK’s International Analgesic
3.6.5 Panadol Sales Forecast, 2009-2024
3.6.6 Nicabate/NicoDerm/Nicorette/NiQuitin Smoking Cessation Brands
3.6.7 Nicabate/NicoDerm/Nicorette/NiQuitin Sales Forecast, 2009-2024
3.6.8 alli: Pioneer OTC-Switch Diet Aid
3.6.9 alli Sales Forecast, 2009-2024
3.6.10 Other GSK Products with Revenues over $100m
3.7 Bayer
3.7.1 Bayer Consumer Care
3.7.2 Bayer’s OTC Pharmaceuticals: 2008 Sales and Market Shares
3.7.3 Bayer OTC Pharmaceutical Forecast, 2009-2014
3.7.4 Bayer Aspirin
3.7.5 Bayer Aspirin Sales Forecast, 2009-2024
3.7.6 Other Bayer OTC Pharmaceuticals
3.8 Novartis
3.8.1 Novartis OTC Pharmaceuticals
3.8.2 Sales and Market Share of Leading Novartis OTC Products in 2008
3.8.3 Novartis OTC Pharmaceutical Forecast, 2009-2014
3.8.4 Voltaren
3.8.5 Novartis’ Nicotine Replacement Business
3.8.6 Otriven, Theraflu, Excedrin and Lamisil: Other Leading Novartis OTC Brands
3.9 Proctor & Gamble
3.9.1 Proctor & Gamble OTC Pharmaceuticals
3.9.2 Prilosec OTC
3.9.3 Prilosec OTC Will Face Competition from Generics and Newer OTC Heartburn Drugs
3.9.4 Vicks
3.9.5 Vicks Market Forecast, 2009-2024
3.10 Wyeth/Pfizer
3.10.1 Wyeth Consumer Healthcare
3.10.2 Wyeth OTC Pharmaceuticals: 2008 Sales and Market Shares
3.10.3 Advil
3.10.4 Advil Market Forecast, 2009-2024
3.11 Sanofi-Aventis
3.11.1 Sanofi-Aventis OTC Division
3.11.2 Sales and Market Share of Sanofi-Aventis OTC Pharmaceuticals
3.12 Reckitt Benckiser
3.12.1 Reckitt Benckiser OTC Pharmaceuticals
3.12.2 Sales and Market Share of Reckitt Benckiser OTC Pharmaceuticals
3.13 Boehringer Ingelheim
3.13.1 Boehringer Ingelheim Consumer Health Care
3.13.2 Sales and Market Share of Leading Boehringer Ingelheim OTC Pharmaceuticals
3.13.3 The Dulcolax Franchise
3.13.4 Mucosolvan/Lasolvan and other Leading OTC Products
3.14 Perrigo
3.14.1 Perrigo Consumer Healthcare
3.14.2 Perrigo OTC Pharmaceuticals

4 OTC Switching
4.1 Motivations for OTC Switching
4.2 Recent OTC-Switching Activity
4.3 The Future Prospects for OTC Switching
4.4 Interview with Joshua P. Cohen, Ph.D., Senior Research Fellow at the Tufts Center for the Study of Drug Development
4.4.1 Prospects for OTC Statins in the US
4.4.2 Future OTC Switching Categories
4.4.3 Prospects for Behind-the Counter in the US
4.4.4 OTC Safety Issues
4.5 Gastrointestinal OTC Switching
4.5.1 H2-Blockers
4.5.2 PPIs Focus of Gastrointestinal OTC Switching
4.5.3 Omeprazole
4.5.4 Lansoprazole
4.5.5 Pantoprazole
4.5.6 Esomeprazole
4.5.7 Rabeprazole
4.5.8 Anti-Obesity OTC Switches
4.6 Cough, Cold and Allergy OTC Switching
4.6.1 First Generation Antihistamines
4.6.2 Second Generation Antihistamines
4.6.3 Third Generation Antihistamine
4.6.4 Fluticasone Propionate
4.7 Analgesic OTC Switching
4.7.1 Triptans
4.7.2 What are the Prospects for OTC Switching of Triptans in the US?
4.7.3 Arthritis Pain
4.8 Dermatological Drugs
4.9 Other OTC-Switching Categories
4.9.1 Oral Contraceptives
4.9.2 Cholesterol-Lowering Drugs
4.9.2.1 OTC Statins
4.9.2.2 The UK’s Zocor Heart-Pro
4.9.2.3 The Road to OTC Statins in the US
4.9.2.4 What are the Worldwide Prospects for Statin OTC Switching?
4.9.3 Erectile Dysfunction Drugs
4.10 OTC Switching: A Continuing Trend during 2009-2024

5 Issues Affecting the OTC Pharmaceutical Industry
5.1 SWOT Analysis of the OTC Pharmaceutical Industry
5.2 OTC Switching
5.3 Brand Identity and Private Labels
5.4 Developments in OTC Retail Channels
5.5 Will OTC Move Behind-the-Counter?
5.6 Web 2.0 Advertising Opportunities
5.7 Changing World Demographics
5.7.1 Population Increase and ‘Greying’ of the World Population
5.7.2 Emerging-Market Economies
5.8 The Worldwide Downturn in Consumer Spending, 2009-2010
5.9 Safety Concerns, Misuse and Abuse of OTC Pharmaceuticals
5.9.1 Safety Concerns
5.9.2 OTC Drug Misuse
5.9.3 OTC Drug Abuse
5.9.4 Impact on the OTC Industry

6 Leading OTC Pharmaceutical Country Markets
6.1 Leading OTC Country Markets in 2008
6.2 Leading OTC Country Markets Forecasts, 2009-2024
6.3 The US OTC Market
6.4 The Japanese OTC Market
6.5 European OTC Markets
6.6 Emerging OTC Markets

7 Conclusions
7.1 The Global OTC Market in 2008
7.1.1 Leading OTC Categories
7.1.2 Leading OTC Brands
7.1.3 Leading OTC Pharmaceutical Manufacturers
7.1.4 Leading OTC Country Markets
7.2 Global OTC Pharmaceutical Market Forecast, 2009-2024
7.2.1 OTC Growth Drivers
7.2.2 OTC Switching Activity
7.2.3 Emerging OTC Markets
7.3 Future OTC Market Dynamics

List of Tables
Table 2.1 OTC Internal Analgesic Active Ingredients
Table 2.2 OTC External Analgesic Active Ingredients
Table 2.3 Cough, Cold and Allergy OTC Pharmaceutical Active Ingredients
Table 2.4 Antifungal OTC Pharmaceutical Active Ingredients
Table 2.5 Indigestion and Heartburn OTC Pharmaceutical Active Ingredients
Table 2.6 Anti-Diarrhoea OTC Pharmaceutical Active Ingredients
Table 2.7 OTC Laxative Active Ingredients
Table 2.8 Nicotine Replacement Therapy OTC Formulations
Table 3.1 OTC and Prescription-Only Pharmaceutical Markets, 2008
Table 3.2 World OTC Pharmaceuticals Sales Forecast, 2009-2014
Table 3.3 World OTC Pharmaceuticals Sales Forecast, 2015-2024
Table 3.4 OTC Category Revenues and Market Share, 2008
Table 3.5 OTC Category Sales Forecast, 2009-2024
Table 3.6 Top Eight OTC Brands, 2008
Table 3.7 Top Ten OTC Pharmaceutical Manufacturers, 2008
Table 3.8 Johnson & Johnson OTC Brands: 2008 Sales Revenues and Market Share
Table 3.9 Johnson & Johnson Total OTC Pharmaceuticals Sales Forecast, 2009-2014
Table 3.10 Tylenol Products, 2009
Table 3.11 Tylenol Sales Forecast, 2009-2014
Table 3.12 Tylenol Sales Forecast, 2015-2024
Table 3.13 Nicorette Formulations (Johnson & Johnson), 2009
Table 3.14 Nicorette (Johnson & Johnson) Sales Forecast, 2009-2014
Table 3.15 Nicorette (Johnson & Johnson) Sales Forecast, 2015-2024
Table 3.16 GSK OTC Brands: 2008 Sales Revenues and Market Share
Table 3.17 GSK Total OTC Pharmaceuticals Forecast, 2009-2014
Table 3.18 Panadol Formulations, 2009
Table 3.19 Panadol Sales Forecast, 2009-2014
Table 3.20 Panadol Sales Forecast, 2015-2024
Table 3.21 Nicabate/NicoDerm/Nicorette/NiQuitin NRT Brands (GSK), 2009
Table 3.22 Nicabate/NicoDerm/Nicorette/NiQuitin (GSK) Sales Forecast, 2009-2014
Table 3.23 Nicabate/NicoDerm/Nicorette/NiQuitin (GSK) Sales Forecast, 2015-2024
Table 3.24 alli Sales Forecast, 2009-2014
Table 3.25 alli Sales Forecast, 2015-2024
Table 3.26 Bayer OTC Brands: 2008 Sales Revenues and Market Share
Table 3.27 Bayer Total OTC Pharmaceuticals Forecast, 2009-2014
Table 3.28 Bayer Aspirin Formulations, 2009
Table 3.29 Bayer Aspirin Sales Forecast, 2009-2014
Table 3.30 Bayer Aspirin Sales Forecast, 2015-2024
Table 3.31 Novartis OTC Brands: 2008 Sales Revenues and Market Share
Table 3.32 Novartis Total OTC Pharmaceuticals Forecast, 2009-2014
Table 3.33 Novartis OTC Nicotine Replacement Therapy Products, 2009
Table 3.34 Proctor & Gamble OTC Brands: 2008 Sales Revenues and Market Share
Table 3.35 Prilosec OTC Sales Forecast, 2009-2014
Table 3.36 Prilosec OTC Sales Forecast, 2015-2024
Table 3.37 Vicks US Formulations, 2009
Table 3.38 Vicks Sales Forecast, 2009-2014
Table 3.39 Vicks Sales Forecast, 2015-2024
Table 3.40 Wyeth OTC Brands: 2008 Sales Revenues and Market Share
Table 3.41 Advil North American Formulations, 2009
Table 3.42 Advil Sales Forecast, 2009-2014
Table 3.43 Advil Sales Forecast, 2015-2024
Table 3.44 Sanofi-Aventis OTC Brands: 2008 Sales Revenues and Market Share
Table 3.45 Reckitt Benckiser OTC Brands: 2008 Sales Revenues and Market Share
Table 3.46 Boehringer Ingelheim OTC Brands: 2008 Sales Revenues and Market Share
Table 4.1 Recent and Future Gastrointestinal OTC Switches
Table 4.2 Recent and Future Cough, Cold & Allergy OTC Switches
Table 4.3 Recent and Future Analgesic OTC Switches
Table 4.4 Recent and Future Dermatological OTC Switches
Table 4.5 Other Possible Future OTC Switches
Table 5.1 SWOT Analysis of the OTC Pharmaceutical Sector, 2009
Table 5.2 World Population Forecast, 2008-2024
Table 5.3 Population Forecasts in Leading OTC Markets, 2008 & 2024
Table 5.4 GDP Forecast for Leading OTC Markets, 2008-2024
Table 6.1 OTC Revenues in Leading OTC Country Markets, 2008
Table 6.2 Leading OTC Country Markets Forecasts, 2009-2024

List of Figures
Figure 2.1 The OTC Pharmaceutical Supply Chain
Figure 3.1 OTC and Prescription-Only Pharmaceutical Markets, 2008
Figure 3.2 World OTC Pharmaceuticals Sales Forecast, 2009-2024
Figure 3.3 OTC Therapies (inc. Vitamins and Minerals) Revenues and Market Shares, 2008
Figure 3.4 OTC Category Revenues and Market Share, 2008
Figure 3.5 OTC Category Sales Forecast, 2009-2024
Figure 3.6 OTC Category Market Share Forecast, 2009-2024
Figure 3.7 Top Ten OTC Pharmaceutical Manufacturers, 2008
Figure 3.8 Top Ten OTC Manufacturers’ Market Shares, 2008
Figure 3.9 Johnson & Johnson OTC Brands: 2008 Market Share
Figure 3.10 Johnson & Johnson Total OTC Pharmaceuticals Sales Forecast, 2009-2014
Figure 3.11 Tylenol Sales Forecast, 2009-2024
Figure 3.12 Nicorette (Johnson & Johnson) Sales Forecast, 2009-2024
Figure 3.13 GSK OTC Brands: 2008 Market Share
Figure 3.14 GSK Total OTC Pharmaceuticals Sales Forecast, 2009-2014
Figure 3.15 Panadol Sales Forecast, 2009-2024
Figure 3.16 Nicabate/NicoDerm/Nicorette/NiQuitin (GSK) Sales Forecast, 2009-2024
Figure 3.17 alli Sales Forecast, 2009-2024
Figure 3.18 Bayer OTC Brands: 2008 Market Share
Figure 3.19 Bayer Total OTC Pharmaceuticals Sales Forecast, 2009-2014
Figure 3.20 Bayer Aspirin Sales Forecast, 2009-2024
Figure 3.21 Novartis OTC Brands: 2008 Market Share
Figure 3.22 Novartis Total OTC Pharmaceuticals Sales Forecast, 2009-2014
Figure 3.23 Proctor & Gamble OTC Brands: 2008 Market Share
Figure 3.24 Prilosec OTC Sales Forecast, 2009-2024
Figure 3.25 Vicks Sales Forecast, 2009-2024
Figure 3.26 Wyeth OTC Brands: 2008 Market Share
Figure 3.27 Advil Sales Forecast, 2009-2024
Figure 3.28 Sanofi-Aventis OTC Brands: 2008 Market Share
Figure 3.29 Reckitt Benckiser OTC Brands: 2008 Market Share
Figure 3.30 Boehringer Ingelheim OTC Brands: 2008 Market Share
Figure 5.1 World Population Forecast, 2008-2024
Figure 5.2 Forecasted World Population Aged 65 or Over, 2008-2024
Figure 5.3 Population Forecasts in Leading OTC Markets, 2008 & 2024
Figure 5.4 GDP Forecast for Leading OTC Markets, 2008-2024
Figure 6.1 Market Share of Leading OTC Country Markets, 2008
Figure 6.2 Forecast Market Share of Leading OTC Country Markets, 2014
Figure 6.3 Forecast Market Share of Leading OTC Country Markets, 2019
Figure 6.4 Forecast Market Share of Leading OTC Country Markets, 2024
Figure 7.1 World OTC Pharmaceuticals Sales Forecast, 2009-2024

Companies Listed

Alliance Boots
Abbott
Adams Respiratory Therapeutics (Reckitt Benckiser)
American Medical Association
AmerisourceBergen
AstraZeneca
AZ Tika (AstraZeneca)
Barr (Teva)
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Cardinal Health
Celesio
Chattem
CNS (GSK)
Daiichi Sankyo
Dexcel
Dr. Reddy’s Laboratories
Eisai
European Medicines Agency (EMEA)
Federal Trade Commission (US)
Food and Drug Administration (FDA) (US)
Galpharm (Perrigo)
GlaxoSmithKline (GSK)
Johnson & Johnson
Kowa
Lion
McKesson
Medicines and Healthcare products Regulatory Agency (MHRA) (UK)
Menarini
Merck & Co.
Ministry of Health, Labour and Welfare (MHLW) (Japan)
Mylan
Novartis
Nycomed
Perrigo
Pfizer
Phoenix
Proctor & Gamble
Public Citizen (US)
Ranbaxy
Ratiopharm
Reckitt Benckiser
Roche
Rohto
Sagmel (Bayer)
Sanofi-Aventis
Santarus
Sato
Schering-Plough
SSL International
SSP
Sun
Symbion Consumer (Sanofi-Aventis)
Taisho
Takeda
Target
Teva
Therapeutic Goods Administration (TGA) (Australia)
Topsun (Bayer)
Walmart
Wyeth

YOU MIGHT BE INTERESTED IN

The Global OTC Pharmaceutical Market 2010-2025

World Smoking-Cessation Drug Market 2010-2025

The Global Analgesics Market 2009-2024

World Respiratory Disorders Market 2009-2024

The World Antibacterial Treatments Market 2010-2024

The US Pharmaceutical Market 2009-2024

The World Dermatological Market Outlook 2010-2024

REPORT

The Global OTC Pharmaceutical Market 2009-2024

Report Details

Table of Contents

Companies Listed